Disclosure Of Cash Flow Statement [Text Block]

ABIVAX - Filing #5984181

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
144 221 EUR
251 942 EUR
26 950 EUR
60 701 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.